Reuters logo
5 个月前
BRIEF-Gemphire qtrly net loss attributable to common stockholders $7.2 mln
2017年3月15日 / 晚上9点56分 / 5 个月前

BRIEF-Gemphire qtrly net loss attributable to common stockholders $7.2 mln

1 分钟阅读

March 15 (Reuters) - Gemphire Therapeutics Inc

* Gemphire announces fiscal year 2016 financial results and provides corporate update

* Gemphire therapeutics inc- cash and cash equivalents at december 31, 2016 totaled $24.0 million compared to $3.6 million at december 31, 2015

* Gemphire therapeutics inc - qtrly net loss attributable to common stockholders was $7.2 million compared to $3.8 million for three months ended december 31, 2015 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below